Itch and atopic dermatitis: An overview

Journal of Dermatology

Volumn 26, Issue 11, 1999, Pages 770-779

  Wahlgren, Carl Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Eczema; Mediators; Pathophysiology; Pruritus; Therapy

Indexed keywords

ATOPIC DERMATITIS; BEHAVIOR THERAPY; CLINICAL FEATURE; ENERGY CONSUMPTION; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PHOTOTHERAPY; PRURITUS; REVIEW; SCRATCHING; SLEEP DISORDER;

EID: 0033401592     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02090.x     Document Type: Review

References (118)

1. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis, Acta Derm Venereol (Stockh), suppl 92: 44-47, 1980.
2. Williams HC, Burney PGJ, Pembroke AC, Hay RJ: The U.K. working party's diagnostic criteria for atopic dermatitis, III. Independent hospital validation, Br J Dermatol, 131: 406-416, 1994.
3. Schnyder UW: Neurodermitis vom klinisch-dermatologischen Standpunkt, Acta Allergol, 16: 463-472, 1961.
4. Hägermark Ö, Wahlgren CF: Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms, J Dermatol Sci, 4: 55-62, 1992.
5. Wahlgren CF: Measurement of itch, Semin Dermatol, 14: 277-284, 1995.
6. Rajka G, Langeland T: Grading of the severity of atopic dermatitis, Acta Derm Venereol (Stockh), suppl 144: 13-14, 1989.
7. Costa C, Rilliet A, Nicolet M, Saurat J-H: Scoring atopic dermatitis: The simpler the better?, Acta Derm Venrreol (Stockh), 69: 41-45, 1989.
8. European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: The SCO-RAD index. Consensus report of the European task force on atopic dermatitis, Dermatology, 186: 23-31, 1993.
9. Kimura T, Miyazawa H: The 'butterfly' sign in patients with atopic dermatitis: Evidence for the role of scratching in the development of skin manifestations, J Am Acad Dermatol, 21: 579-580, 1989.
10. Goldblum RW, Piper WN: Artificial lichenification produced by a scratching machine, J Invest Dermatol, 22: 405-415, 1954.
11. Jacquet L: Prurigo, in Besnier E, Brocq L, Jacquet L (eds): La Pratique Dermatologique, vol 4, Masson, Paris, 1904, pp 44-87.
12. Hanifin JM: Basic and clinical aspects of atopic dermatitis, Ann Allergy, 52: 386-393, 1984.
13. Graham DT, Wolf S: The relation of eczema to attitude and to vascular reactions of the human skin, J Lab Clin Med, 42: 238-254, 1953.
14. Wahlgren CF: Itch and atopic dermatitis: Clinical and experimental studies, Acta Derm Venereol (Stockh), suppl 165: 1-53, 1991.
15. Bickford RG: Experiments relating to the itch sensation, its peripheral mechanism, and central pathways, Clin Sci, 3: 377-386, 1937-1938.
16. Wall PD: Why does scratching relieve itching? [abstract], Skin Pharmacol, 2: 219, 1989.
17. Greaves MW, Wall PD: Pathophysiology of itching, Lancet, 348: 938-940, 1996.
18. Elliott BE, Luker K: The experiences of mothers caring for a child with severe atopic eczema, J Clin Nursing, 6: 241-247, 1997.
19. Savin JA, Paterson WD, Oswald I: Scratching during sleep, Lancet, 2: 296-297, 1973.
20. Savin JA, Paterson WD, Oswald I, Adam K: Further studies of scratching during sleep, Br J Dermatol, 93: 297-302, 1975.
21. Aoki T, Kushimoto H, Kobayashi E, Ogushi Y: Computer analysis of nocturnal scratch in atopic dermatitis, Acta Derm Venereol (Stockh), suppl 92: 33-37, 1980.
22. Monti JM, Vignale R, Monti D: Sleep and nighttime pruritus in children with atopic dermatitis, Sleep, 12: 309-314, 1989.
23. Aoki T, Kushimoto H, Hishikawa Y, Savin JA: Nocturnal scratching and its relationship to the disturbed sleep of itchy subjects, Clin Exp Dermatol, 16: 268-272, 1991.
24. Jenney MEM, Childs C, Mabin D, Beswick MV, David TJ: Oxygen consumption during sleep in atopic dermatitis, Arch Dis Child, 72: 144-146, 1995.
25. Ebata T, Aizawa H, Kamide R: An infrared video camera system to observe nocturnal scratching in atopic dermatitis patients, J Dermatol, 23: 153-155, 1996.
26. Endo K, Sumitsuji H, Fukuzumi T, Adachi J, Aoki T: Evaluation of scratch movements by a new scratch-monitor to analyze nocturnal itching in atopic dermatitis, Acta Derm Venereol (Stockh), 77: 432-435, 1997.
27. Stores GS, Burrows A, Crawford C: Physiological sleep disturbance in children with atopic dermatitis: A case control study, Pediatr Dermatol, 15: 264-268, 1998.
28. Reid P, Lewis-Jones MS: Sleep difficulties and their management in preschoolers with atopic eczema, Clin Exp Dennalol, 20: 38-41, 1995.
29. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S: Sleep disturbances in children with atopic dermatitis, Arch Pediatr Adolesc Med, 149: 856-860, 1995.
30. Bartlet LB, Westbroek R, White JE: Sleep patterns in children with atopic eczema, Acta Derm Venereol (Stockh), 77: 446-468, 1997.
31. Felix R, Shuster S: A new method for the measurement of itch and the response to treatment, Br J Dermatol, 93: 303-312, 1975.
32. David TJ, Ferguson AP, Newton RW: Nocturnal growth hormone release in children with short stature and atopic dermatitis, Acta Derm Venereol (Stockh), 71: 229-231, 1991.
33. Hägermark Ö: The pathophysiology of itch, in Ruzicka T, Ring J, Przybilla B (eds): Handbook of Atopic Eczema, Springer-Verlag, Berlin, 1991, p 278-286.
34. Heyer G, Ulmer FJ, Schmitz J, Handwerker HO: Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls, Acta Derm Venereol (Stockh), 75: 348-352, 1995.
35. Hägermark Ö, Wahlgren CF: Itch in atopic dermatitis: The role of histamine and other mediators and the failure of antihistamine therapy, Dermatol Ther, 1: 75-82, 1996.
36. Wahlgren CF, Scheynius A, Hägermark Ö: Antipruritic effect of oral cyclosporin A in atopic dermatitis, Acta Derm Venereol (Stockh), 70: 323-329, 1990.
37. Wahlgren CF: Pathophysiology of itching in urticaria and atopic dermatitis, Allergy, 47: 65-75, 1992.
38. Hägermark Ö: Peripheral and central mediators of itch, Skin Pharmacol, 5: 1-8, 1992.
39. Cremer B, Heimann A, Dippel E, Czarnetzki BM: Pruritogenic effects of mitogen-stimulated peripheral blood mononuclear cells in atopic eczema, Acta Derm Venereol (Stockh), 75: 426-428, 1995.
40. Lippert U, Hoer A, Möller A, Ramboer I, Cremer B, Henz BM: Role of antigen-induced cytokine release in atopic pruritus, Int Arch Allergy Immunol, 116: 36-39, 1998.
41. Koenigstein H: Experimental study of itch stimuli in animals, Arch Dermatol Syphilol, 57: 828-849, 1948.
42. Ballantyne JC, Loach AB, Carr DB: Itching after epidural and spinal opiates, Pain, 33: 149-160, 1988.
43. Bernstein JE, Swift RM, Soltani K, Lorincz AL: Antipruritic effect of an opiate antagonist, naloxone hydrochloride, J Invest Dermatol, 78: 82-83, 1982.
44. Bergasa NV, Talbot TL, Ailing DW, et al: A controlled trial of naloxone infusions for the pruritus of chronic cholestasis, Gastroenterology, 102: 544-549, 1992.
45. Thornton JR, Losowsky MS: Opioid peptides and primary biliary cirrhosis, BMJ, 297: 1501-1504, 1988.
46. Monroe EW: Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis, J Am Acad Dermatol, 21: 135-136, 1989.
47. Hägermark Ö: Pruritus, in Fry L (ed): Skin Problems in the Elderly, Churchill Livingstone, Edinburgh-London-Melbourne-New York, 1985, pp 267-292.
48. Hägermark Ö: Recent advances in the pathophysiology of itch, Allergologie, 12: s139-s142, 1989.
49. Arthur RP, Shelley WB: The nature of itching in dermatitic skin, Ann Intern Med, 49: 900-908, 1958.
50. Rajka G: Itch duration in the involved skin of atopic dermatitis (prurigo Besnier), Acta Derm Venereol (Stockh), 47: 154-157, 1967.
51. Rajka G: Itch duration in the uninvolved skin of atopic dermatitis (prurigo Besnier), Acta Derm Venereol (Stockh), 48: 320-321, 1968.
52. Harnack K: Experimental itch as a diagnostic method, Acta Derm Venereol (Stockh), suppl 92: 40-41, 1980.
53. Heyer G, Hornstein OP, Handwerker HO: Skin reactions and itch sensation induced by epicutaneotis histamine application in atopic dermatitis and controls, J Invest Dermatol, 93: 492-496, 1989.
54. Wahlgren GF, Hägermark Ö, Bergstrom R: Patients' perception of itch induced by histamine, compound 48/80 and wool fibers in atopic dermatitis, Acta Derm Venereol (Stockh), 71: 488-494, 1990.
55. LaMotte RH, Simone DA, Baumann TK, Shain CN, Alreja M: Hypothesis for novel classes of chemoreceptors mediating chemogenic pain and itch, in Dubner R, Gebhart GF, Bond MR (eds): Proceedings of the Vth World Congress on Pain, Elsevier Science Publishers BV, Amsterdam, 1988, pp 529-535.
56. Simone DA, Alreja M, LaMotte RH: Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine, Somatosens Mol Res, 8: 271-279, 1991.
57. Handwerker HO: Pain and allodynia, itch and alloknesis: An alternative hypothesis, APS Journal, 1: 135-138, 1992.
58. Hambly EM, Levia L, Wilkinson DS: Wool intolerance in atopic subjects, Contact Dermatitis, 4: 240-241, 1978.
59. Bendsöe N, Björnberg A, Åsnes H: Itching from wool fibres in atopic dermatitis, Contact Dermatitis, 17: 21-22, 1987.
60. Pallagrosi AU: Betamethasone dipropionate (diprosone): A new topical steroid. A multinational, multicenter evaluation, J Int Med Res, 3: 275-278, 1975.
61. Wahlgren CF, Hägermark Ö, Bergström R, Hedin B: Evaluation of a new method of assessing pruritus and antipruritic drugs, Skin Pharmacol, 1: 3-13, 1988.
62. Thoma K: Topical vehicles: Composition, principles of application and action, in Ruzicka T, Ring J, Przybilla B (eds): Handbook of Atopic Dermatitis, Springer-Verlag, Berlin-Heidelberg, 1991, pp 364-374.
63. Lodén M: The increase in skin hydralion after application of emollients with different amounts of lipids, Acta Derm Venereol (Stockh), 72: 327-330, 1992.
64. Hannuksela A, Kinnunen T: Moisturizers prevent irritant dermatitis, Acta Derm Venereol (Stockh), 72: 42-44, 1992.
65. Przybilla B, Eberlein-König B, Rueff F: Practical management of atopic eczema, Lancet, 343: 1342-1346, 1994.
66. Hanifin J, Chang SC: Diagnosis and treatment of atopic dermatitis, Dermatol Ther, 1: 9-18, 1996.
67. Fruhstorfer H, Hermanns M, Latzke L: The effects of thermal stimulation on clinical and experimental itch, Pain, 24: 259-269, 1986.
68. 2 receptor antagonists in the treatment of alopic dermatitis, Arch Dermatol Res, 276: 36-40, 1984.
69. Savin JA, Dow R, Harlow BJ, Massey H, Yee KF: The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema, Clin Exp Dermatol, 11: 600-602, 1986.
70. Berth-Jones J, Graham-Brown RAC: Failure of terfenadine in relieving the pruritus of atopic dermatitis, Br J Dermatol, 121: 635-637, 1989.
71. Wahlgren CF, Hägermark Ö, Bergström R: The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis, Br J Dermatol, 122: 545-551, 1990.
72. Henz BM, Metzenauer P, O'Keefe E, Zuberbier T: Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses, Allergy, 53: 180-183, 1998.
73. Doherty V, Sylvester DGH, Kennedy CTC, Harvey SG, Calthrop JG, Gibson JR: Treatment of itching in atopic eczema with antihistamines with a low sedative profile, BMJ, 298: 96, 1989.
74. Monroe EW: Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis, Clin Ther, 14: 17-21, 1992.
75. Hannuksela M, Kalimo K, Lammintausta K, et al: Dose ranging study: Cetirizine in the treatment of atopic dermatitis in adults, Ann Allergy, 70: 127-133, 1993.
76. Langeland T, Fagertun HE, Larsen S: Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis, Allergy, 49: 22-26, 1994.
77. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA: Double-blind study of cetirizine in atopic eczema in children, Ann Allergy, 73: 117-122, 1994.
78. 1 antagonism in allergic inflammation, J Allergy Clin Immunol, 86: 1019-1024, 1990.
79. Krause L, Sinister S: Mechanism of action of antipruritic drugs, BMJ, 287: 1199-1200, 1983.
80. Ebata T, Izumi H, Aizawa H, Kamide R, Niimura M: Effects of nitrazepam on nocturnal scratching in adults with atopic dermatitis: A double-blind placebo-controlled crossover study, Br J Dermatol, 138: 631-634, 1998.
81. Berth-Jones J, Graham-Brown RAC, Marks R, et al: Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis, Br J Dermatol, 136: 76-81, 1997.
82. Wahlgren CF, Tengvall Linder M, Scheynius A: Effects of cyclosporin A in atopic dermatitis: Expression in the skin of IgE, low-affinity Fc-IgE receptors, ICAM-1 and eosinophilic granulocytes, Eur J Dermatol, 2: 112-118, 1992.
83. van Joost T, Kozel MMA, Tank B, Troost R, Prens EP: Cyclosporine in atopic dermatitis, J Am Acad Dermatol, 27: 922-928, 1992.
84. Garnier-Lyonnet S, Thivolet J, van Dongen M, Viac J, Frappaz A: Cyclosporin A improves severe atopic dermatitis in adults and reduces activated CD4+ T lymphocytes, Eur J Dermatol, 5: 481-485, 1995.
85. Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H: Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment, Br J Dermatol, 133: 494-496, 1995.
86. Ruzicka T, Bieber T, Schöpf E, et al: A short-term trial of tacrolimus ointment for atopic dermatitis, N Engl J Med, 337: 816-821, 1997.
87. Jekler J, Larkö O: Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired-comparison study, J Am Acad Dermatol, 22: 49-53, 1990.
88. Ekblom A, Fjellner B, Hansson P: The influence of mechanical vibratory stimulation and transcutaneous electrical nerve stimulation on experimental pruritus induced by histamine, Acta Physiol Scand, 122: 361-367, 1984.
89. Lundeberg T, Bondesson L, Thomas M: Effect of acupuncture on experimentally induced itch, Br J Dermatol, 117: 771-777, 1987.
90. Fjellner B, Hägermark Ö: Transcutaneous nerve stimulation and itching, Acta Derm Venereol (Stockh), 58: 131-134, 1978.
91. Nilsson H-J, Levinsson A, Schouenborg J: Cutaneous field stimulation (CFS): A new powerful method to combat itch, Pain, 71: 49-55, 1997.
92. Nilsson H-J, Schouenborg J: Differential inhibitory effect on human nociceptive skin senses induced by local stimulation of thin cutaneous fibers, Pain, 80: 103-112, 1999.
93. Nilsson H-J, Carstam R, Schouenborg J: Profound and long lasting inhibition of chronic itch induced by stimulation of thin cutaneous nerve fibers, 1999. (submitted)
94. Melin L, Frederiksen T, Norén P, Swebilius BG: Behavioural treatment of scratching in patients with atopic dermatitis, Br J Dermatol, 115: 467-474, 1986.
95. Norén P, Melin L: The effect of combined topical steroids and habit reversal treatment in patients with atopic dermatitis, Br J Dermatol, 121: 359-366, 1989.
96. Lewis T: The Blood Vessels of the Human Skin and Their Responses, Shaw & Sons, London, 1927.
97. Lewis T, Grant RT, Marvin HM: Vascular reactions of the skin to injury, Heart, 14: 139-160, 1927-1929.
98. Fjellner B, Hägermark Ö: Pruritus in polycythemia vera: Treatment with aspirin and possibility of platelet involvement, Acta Derm Venereol (Stockh), 59: 505-512, 1979.
99. Shelley WB, Arthur RP: The neurohistology and neurophysiology of the itch sensation in man, Arch Dermatol, 76: 296-323, 1957.
100. Hägermark Ö, Rajka G, Bergqvist U: Experimental itch in human skin elicited by rat mast cell chymase, Acta Derm Venereol (Stockh), 52: 125-128, 1972.
101. Arthur RP, Shelley WB: The role of proteolytic enzymes in the production of pruritus in man, J Invest Dermatol, 25: 341-346, 1955.
102. Hägermark Ö: Influence of antihistamines, sedatives, and aspirin on experimental itch, Acta Derm Venereol (Stockh), 53: 363-368, 1973.
103. Lovell CR, Burton PA, Duncan EHL, Burton JL: Prostaglandins and pruritus, Br J Dermatol, 94: 273-275, 1976.
104. Hägermark Ö: Studies on experimental itch induced by kallikrein and bradykinin, Acta Derm Venereol (Stockh), 54: 397-400, 1974.
105. Fjellner B, Hägermark Ö: Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters, Acta Derm Venereol (Stockh), 61: 245-250, 1981.
106. Hägermark Ö, Hökfelt T, Pernow B: Flare and itch induced by substance P in human skin, J Invest Dermatol, 71: 233-235, 1978.
107. Fjellner B, Hägermark Ö: Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33-824, β-endorphin and morphine, Arch Dermatol Res, 274: 29-37, 1982.
108. Greaves MW, McDonald-Gibson W: Itch: Role of prostaglandins, BMJ, 3: 608-609, 1973.
109. Hägermark Ö, Strandberg K, Hamberg M: Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog, J Invest Dermatol, 69: 527-530, 1977.
110. Hägermark Ö, Strandberg K: Pruritogenic activity of prostaglandin E2, Acta Derm Venereol (Stockh), 57: 37-43, 1977.
111. Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport MJ: Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4, Br J Pharmacol, 80: 497-502, 1983.
112. Fjellner B, Hägermark Ö: Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin, Acta Derm Venereol (Stockh), 65 409-412, 1985.
113. Wahlgren CF, Tengvall Linder M, Hägermark Ö, Scheynius A: Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects, Arch Dermatol Res, 287: 572-580, 1995.
114. Darsow U, Scharein E, Bromm B, Ring J: Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-α) at the dermal-epidermal junction, Br J Dermatol, 137: 415-417, 1997.
115. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M: Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1, J Invest Dermatol, 96: 690-694, 1991.
116. Vogelsang M, Heyer G, Hornstein OP: Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects, Acta Derm Venereol (Stockh), 75: 434-436, 1995.
117. Heyer G, Vogelsang M, Hornstein OP: Acetylcholine is an inducer of itching in patients with atopic eczema, J Dermatol, 24: 621-625, 1997.
118. Leiferman KM, Loegering DA, Gleich GJ: Production of wheal-and-flare skin reactions by eosinophil granule proteins [abstract], J Invest Dermatol, 82: 414, 1984.